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1. Introduction 
Cancer development is a result of interactions among environmental and hereditary factors 
(Kim, 2006). The majority of genetic abnormalities, which  increase the risk of cancer are not 
hereditary, but a result of DNA damage occurring during lifetime. The causes of DNA 
damage include internal (nutrient metabolism, cell hormones) and/or external factors (diet, 
insufficient physical activity, tobacco use, exposure to chemical agents and radiation) 
(International Life Sciences Institute [ILSI], 2005; World Cancer Research Fund [WCRF], 
2007; Kryston et al., 2011). Epidemiological studies have shown that diet and lifestyle are the 
most important external factors implicated in the development of malignant diseases (ILSI, 
2005; WCRF & AICR, 2007; Go et al., 2003). 
Why the same environmental factors cause different changes in human genome among 
individuals is a question for scientists searching unique combinations of factors leading to 
cancer (Brower, 2011). There is a growing body of evidence that many cancers are not 
caused by mutations in genes, but by chemical modifications that alter the way genes 
function. Chemical modifications of genes are called epigenetic changes. Epidemiological 
studies have shown that diet and lifestyle may cause such changes (Brower, 2011). 
According to World Cancer Report (Boyle & Levin, 2008) 12.4 million new cases of cancer 
were reported in 2008. Malignant diseases accounted for 7.6% of all deaths during the same 
year and estimations are that in 2030, cancers will be responsible for 17.0% of deaths 
worldwide. The number of new cases is expected to rise, especially in developing countries 
(Boyle & Levin, 2008). 
In total, malignancies account for 83 million disability-adjusted life years (DALYs). The 
estimated global economic loss from cancer is US$ 895.2 billion, measured by the economic 
value of DALYs (American Cancer Society & Livestrong, 2010). 
The aforementioned data, coupled with rising health care expenditures for cancer patients, 
led to cancer being seen not only as a health problem, but also as a political issue (WHO, 
2011a, 2011b). Identification of cancers as the leading non-communicable diseases [NCDs], 
together with cardiovascular diseases, type 2 diabetes and chronic obstructive pulmonary 
diseases, was followed by an initiative to include NCDs among the global development 
goals that will succeed the Millennium Development Goals in 2015 (The NCD Alliance, 
2011).  
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Scientists around the world declared war on cancer (Waldorp, 2011). Preventive medicine 
has been recognized as the most promising field in reducing the risk of malignant diseases 
development. As diet and lifestyle are believed to be the most important external factors 
implicated in cancer development, nutrition care process [NCP] (American Dietetic 
Association [ADA], 2006a, 2008) and medical nutrition prevention [MNP] are considered the 
most important tools in cancer risk management (Key et al., 2004; Béliveau & Gingras, 2007).  
NCP and MNP can be used to reduce the potential of nutrition misinformation to increase 
the cancer risks in populations and individuals who are inadequately educated about 
healthy food and lifestyle choices (ADA, 2006b).  
Registered dietitians are well aware of dietary reference values and safe upper limits for 
nutrients intake in different population groups, but these recommendations neglect genetic 
differences in population subgroups. Therefore, special scientific disciplines - nutrigenetics 
and nutrigenomics - study the effects of different foods and food constituents on gene 
expression (Fenech et al., 2011). There is a distinct difference between nutrigenetics and 
nutrigenomics. Nutrigenetics studies effects of genetic variations on body response to diet 
and nutrition, while nutrigenomics studies health effects of gene alterations influenced by 
food constituents (Milner, 2006a). Both disciplines aim to determine the optimal nutrient 
intake and nutrient combinations (called nutriom) in order to sustain the genome and 
support the physiological processes of gene expression, metabolism and cell functioning. 
These findings are expected to be used in cancer risk reduction in dietetic practice (Milner, 
2006a). 
2. Risk factors related to lifestyle and the possibility of cancer prevention 
Many lifestyle factors are related to cancer risks, but at the same time they are highly 
preventable or modifiable. 
2.1 Body composition 
Nutrition transitions, taking place in developing countries since the 20th century, toward 
more energy-dense foods, associated with insufficient physical activity, resulted in 
pandemic prevalence of overweight and obesity (Popkin, 1995). Overweight and obesity are 
metabolic disorders and the leading causes of NCDs. Worldwide, 4.8% of all deaths and 
2.3% of DALYs are attributable to overweight and obesity (WHO, 2009a). 
Overweight and obesity are associated with increased risk of some cancer localizations 
(Calle et al., 2003; Lagergren, 2011; Fontham & Su, 2008; Stoll, 2002; Ma et al., 2008). Visceral 
adiposity and central obesity are risk factors for some cancers (AICR & WCRF, 2009). Fat 
mapping (adipotopography) is an emerging biomedical field dealing with localization and 
amount of intra-abdominal adipose tissue [IAAT] in the human body. Subjects with higher 
amount of intra-abdominal adipose tissue are at greater risk for insulin resistance, diabetes 
and cancer (Thomas et al., 2011). The recommended body-mass index [BMI] for cancer risk 
reduction is 21.5 kg/m2 on a population scale, and between 18.5 kg/m2 and 25.0 kg/m2 on 
individual level (AICR & WCRF, 2009; Food and Agriculture Organization of the United 
Nations [FAO], 2004). Individuals with BMI within the physiological range, but with high-
risk waist circumference [WC], are classified as thin-on-the-outside, fat-on-the-inside [TOFI] 
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phenotype (Thomas et al., 2011) and they are at greater risk of certain cancer localizations. 
TOFI is a pathological phenomenon, synonymous with "metabolically obese", whereas 
thin-on-the-outside, thin-on-the-inside [TOTI] is an acronym for healthy adipose tissue 
distribution (Thomas et al., 2011).  
TOFI phenotype may be used to explain the rising incidence of cancers in developing 
countries. Rapid economic growth and social transitions happening in these countries affect 
dietary and other lifestyle choices. Energy-dense foods become easily accessible to 
consumers, while the level of physical activity decreases, promoting overweight and obesity 
(Popkin, 2001). 
Higher amount of IAAT or visceral adiposity is usually related to increased serum levels of 
insulin-like growth factor [IGF-1], insulin, leptin, sex hormones and adipocytokines (tumor 
necrosis factor-alpha [TNF-α], interleukin-6 [IL-6], C-reactive protein [CRP], adiponectin, 
resistin, visfatin, apelin), all known as cancer and type 2 diabetes risk factors (Donohoe et 
al., 2011; Bon, 2008; Redinger, 2008). Epidemiological studies show that type 2 diabetes 
patients are at higher risk for developing many types of cancer. There is an ongoing effort in 
research of shared risk factors for cancer and type 2 diabetes supported by the American 
Diabetes Association and the American Cancer Society. This research strives to find a 
biological link between cancer and type 2 diabetes, as well as to explain whether diabetes 
mellitus therapy affects the risk for cancer development (Giovannucci et al., 2010). 
Taller individuals are more likely to get cancer, due to cells being stimulated by IGF-1 and 
growth hormone continuously, increasing the possibility of DNA replication error, some of 
which may lead to malignant alterations (Hernandez et al., 2009). 
Overweight and obesity are usually the result of external factors, and are therefore, 
preventable and treatable (WHO, 2005, 2008a) risk factors for some cancers (Table 1). 
 
Cancer site USA [%] UK [%] Brazil [%] China [%] 
Endometrium 70 56 52 34 
Esophagus 69 75 60 44 
Mouth, pharynx & larynx 63 67 63 44 
Stomach 47 45 41 33 
Colon 45 43 37 17 
Pancreas 39 41 34 14 
Breast 38 42 28 20 
Lung 36 33 36 38 
Kidney 24 19 13 8 
Gallbladder 21 16 10 6 
Liver 15 17 6 6 
Prostate 11 20 n/a n/a 
Total for these cancers 
combined 
34 39 30 27 
Total for all cancers 24 26 19 20 
Table 1. Estimated percentage of cancers that could be prevented by healthy diet, regular 
physical activity and healthy weight in selected countries based on the conclusions of the 
2007 WCRF/AICR Diet and Cancer Report (n/a –  exposure data not available). Adapted 
from AICR & WCRF, 2009. 
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According to Fair & Montgomery, "nutritional energy intake is a modifiable factor in the 
energy balance-cancer linkage". Animal studies showed that reduction of energy intake by 
10.0 to 40.0% decreases cell proliferation, by increasing apoptosis due to insufficient 
angiogenesis (Fair & Montgomery, 2009). Although known to have anticarcinogenic 
potential, decreased energy intake alone cannot reduce the risk of cancer, since energy 
expenditure depends highly on the physical activity level. Regular physical activity helps 
weight loss, reduction of IAAT, serum insulin, IGF-1 and adipocytokines levels, hence 
reducing the risk of cancer (WHO, 2008a). 
Body mass reduction and maintenance of healthy body mass calls for accurate 
determination of daily energy requirements (Table 2), depending on age, gender and 
physical activity levels (U.S. Department of Agriculture [USDA] & U.S. Department of 
Health and Human Services, 2011). 
 
  Physical Activity Level 
Gender 
Age 
[years] 
Sedentary 
[kcal/day] 
Moderately active 
[kcal/day] 
Active [kcal/day] 
Child (female and male) 2-3 1000-1200a 1000-1400a 1000-1400a 
Femaleb 4-8 1200-1400 1400-1600 1400-1600 
 9-13 1400-1600 1600-2000 1800-2400 
 14-18 1800 2000 2400 
 19-30 1800-2000 2000-2200 2400 
 31-50 1800 2000 2200 
 51+ 1600 1800 2000-2200 
Male 4-8 1200-1400 1400-1600 1600-2000 
 9-13 1600-1800 1800-2200 2000-2600 
 14-18 2000-2400 2400-2800 2800-3200 
 19-30 2400-2600 2600-2800 3000 
 31-50 2200-2400 2400-2600 2800-3000 
 51+ 2000-2200 2200-2400 2400-2800 
Table 2. Estimated calorie needs per day by age, gender and physical activity level (a. The 
calorie ranges accommodate needs of different ages within the group. Children and 
adolescents need more calories at older ages, and adults need less calories at older ages.; b. 
Not including pregnant and breastfeeding females.) Adapted from: U.S. Department of 
Agriculture [USDA] & U.S. Department of Health and Human Services, 2011. 
High waist circumference (WC) values increase the cancer risks, and they are undoubtedly 
related to all-cause mortality in middle aged men and women (Bigaard et al., 2005). Health 
risks of high waist circumference values in adolescence and young adulthood are similar to 
those of middle aged individuals. Efforts are being made to standardize WC reference data 
in accordance with age, gender, body height and ethnicity. Standardization of WC by BMI, 
site of waist measurement, meal timing and phase of respiration are suggested (Wang, 
2006). According to Wang the "unit for WC standardization that investigators will accept 
logically and mathematically and that would increase the use of WC measurement in the 
clinical field" should be similar to the percentile system used in children's growth rate 
nomograms, or T-score used in bone density evaluation (Wang, 2006). Cut-off values of WC 
by gender and ethnicity are shown in table 3. 
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Country/Ethnic group Gender Waist circumference 
Europidsa 
In the USA, the ATP III values (102 cm male, 88 cm 
female are likely to continue to be used for clinical 
purposes) 
Male > 94 cm 
Female > 80 cm 
South Asians 
Based on Chinese, Malay and Asian-Indian 
population 
Male > 90 cm 
Female > 80 cm 
Japanese 
Use South Asian recommendations until 
more specific data are available 
Ethnic South and Central Americans 
Use South Asian recommendations until 
more specific data are available 
Sub-Saharan Africans 
Use European recommendations until more 
specific data are available 
Eastern Mediterranean and Middle East (Arab) 
populations 
Use European recommendations until more 
specific data are available 
Table 3. Cut-off values of waist circumference by gender and ethnicity excluding children 
younger than 6 years (a. In future epidemiological studies of populations of Europid origin, 
prevalence should be given using both European and North American cut-points to allow 
better comparisons). Table adapted from IDF, 2006. 
Key recommendations for long term maintenance of healthy body mass are as follows 
(Grace, 2011): 
1. Being physically active (at least 60 minutes of moderate physical activity daily),  
2. Choosing low energy and low fat foods,  
3. Eating breakfast regularly,  
4. Monitoring body mass,  
5. Catching body mass gain before it turns into overweight or obesity,  
6. Establishing a consistent healthy diet and proper lifestyle choices.  
2.2 Cancer protective diet versus diet-related cancer risk 
Nutrition is the source of life. Healthy diet with optimal nutrients intake prevents nutrient 
deficiency and helps to maintain or improve health. Types of nutrients and their amounts 
sufficient for sustaining life and maintaining good health are well known and 
recommendations for nutrients intake are given according to age, gender, pregnancy or 
lactation (Smolin & Grosvenor, 2010). A number of factors (e.g. genetic background, 
physical activity level) affect individual's optimal nutrients intake, so it is still not possible 
for dietitians to practice personalized nutrition. 
The inter-individual variability of responses to different food constituents is being 
scrutinized (Simopoulos & Milner, 2010). The scientific position that genetic predisposition 
to complex diseases is a result of small variations of a large number of genes and their 
ability to interact with specific ecological factors is strongly supported in available literature. 
Therefore, results of nutrigenomic and nutrigenetic research could, through practical and 
clinical use of new knowledge, reduce the risk for malignant alterations and help control the 
burden of cancer as the second most common cause of death in the world (Kinsella & He, 
2009; WHO, 2011c). It is expected that nutrigenetics and nutrigenomics will shed some light 
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on the complex relations between nutritional molecules, genetic variations and the 
biological system, thus facilitating the concept of personalized nutrition. Development of 
nutrition guides intended for individual use depends on agricultural production and food 
availability (Simopoulos & Milner, 2010). 
At this moment, only population-based nutrition guides exist. They first appeared in early 
20th century (USDA, 2002). The first significant guide was the Exchange List for Meal 
Planning (American Diabetic Association & ADA, 2003) and it was followed by globally 
accepted MyPyramid (USDA, 2011a). In June 2011, USDA published the enhanced version 
of nutrition guide called ChooseMyPlate (USDA, 2011b), based on Dietary Guidelines for 
Americans, published earlier in 2011 (USDA & U.S. Department of Health and Human 
Services, 2011). The use of nutritional guides is still encouraged in dietetics practice, because 
they can help manage cancer risks by changing diet and lifestyle. 
No specific food can be labelled as anticarcinogenic, but certain food constituents have the 
potential to reduce cancer risks (WCRF & AICR, 2007; WHO, 2003). Diet rich in fresh 
vegetables, fruits and low in red and processed meat has been referred to as 
chemoprotective, while foods with high glycemic indices and sweetened beverages have 
been linked to hyperinsulinemia, overweight, obesity and increased cancer risks (WCRF & 
AICR, 2007; Kushi et al., 2006).  
2.2.1 Grains and grain products 
The amount of nutrients in cereals and cereal products depends on the degree of refinement 
and processing. Dietary fibers, antioxidants, phenols, lignans and phytoestrogens, present in 
whole grain products may reduce the risk for some types of cancer (Schatzkin et al., 2007). 
Dietary fibers are defined as partially or completely indigestible carbohydrates consisting of 
3 or more monosaccharide units (Gray, 2006). "Isolated indigestible carbohydrates shown to 
have beneficial physiological effects in humans" are called functional fibers (Institute of 
Medicine, 2005). The fiber content of carbohydrates, determines the food's glycemic index 
[GI] (Smolin & Grosvenor, 2010; Gray, 2006; Barclay, 2008). Foods labelled with "low GI" on 
nutrition claims (good sources of dietary fibers) are recommended for risk reduction of 
certain cancers (Barclay, 2008; Buttriss & Stokes, 2008). Nutrition (and health) claims have 
enormous potential for chronic diseases risk reduction and health promotion and 
improvement, but better education of consumers on this issue is necessary (Buttriss & 
Stokes, 2008; Jovičić et al., 2010; Bonsmann et al., 2010). Key recommendation concerning 
grains and grain products category is to pay attention to the GI and dietary fiber content per 
100 g or per serving of foods. 
2.2.2 Fruits and vegetables 
During the last decade of the 20th century, scientists started emphasizing that high intake of 
fruits and vegetables may reduce cancer risks. That is why the "5-A-Day" program was 
developed by the American National Cancer Institute (Havas et al., 1994), but later studies 
failed to back up the optimistic findings from the 90s (Boffeta et al., 2010; Willet, 2010; 
Cancer Council Australia, 2007). There is an ongoing effort to find specific fruits and 
vegetables and their constituents (or their interactions) that are responsible for cancer risk 
reduction (Table 4). 
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Organisation Review 
Highest Evidence 
Convincing 
Moderate Evidence 
Probable 
Lower Evidence 
Possible / Limited 
WCRF/AICR (2007)  
Mouth (f&v) 
Pharynx (f&v) 
Larynx (f&v) 
Oesophagus (f&v) 
Stomach (f&v) 
Lung (f) 
Nasopharynx (f&v) 
Colon & rectum (f&v) 
Pancreas (f) 
Liver (f) 
Lung (v) 
Ovary (v) 
Endometrium (v) 
IARC (2003)  
Oesophagus (f&v) 
Stomach (f) 
Colon & rectum (v) 
Mouth (f&v) 
Pharynx (f&v) 
Larynx (f&v) 
Kidney (f&v) 
Colon & rectum (f) 
Bladder (f) 
Stomach (v) 
Lung (v) 
Ovary (v) 
WHO/FAO (2003)  
Oral Cavity (f&v) 
Oesophagus (f&v) 
Stomach (f&v) 
Colon & rectum (f&v) 
 
COMA (1998) Oesophagus (f&v) 
Stomach (f&v) 
Colon & rectum (v) 
Breast (f&v) 
WCRF/AICR (1997) 
Mouth (f&v) 
Pharynx (f&v) 
Oesophagus (f&v) 
Stomach (f&v) 
Colon & rectum (v) 
Lung (f&v) 
Larynx (f&v) 
Pancreas (f&v) 
Breast (f&v) 
Bladder (f&v) 
Ovaries (f&v) 
Cervix (f&v) 
Endometrium (f&v) 
Thyroid (f&v) 
Liver (v) 
Prostate (v) 
Kidney (v) 
Table 4. Conclusions from the major cancer prevention reports regarding the cancer 
protective effect of fruit (f) and vegetables (v). Used with permission of Cancer Council 
Australia (www.cancer.org.au) (Cancer Council Australia, 2007). 
Fruits and vegetables contain dietary fibers, vitamins, minerals and other bioactive 
molecules, as well as a large percentage of water which makes them low-energy foods. 
Replacing high-energy dense foods with fruits and vegetables may lead to body mass 
reduction and, consequently, to cancer risk reduction (Willet, 2010; Cancer Council 
Australia, 2007; Slimani & Margetts, 2009; Novaković et al., 2010). 
Nutritional and health benefits of indigestible oligosaccharides contained in fruits and 
vegetables are being pointed out in scientific journals. Oligosaccharides are dietary fibers 
which are generally highly fermentable. Some oligosaccharides, namely 
fructooligosaccharides, inulin and lactulose are valued for their prebiotic properties (Gray, 
2006; Roberfroid et al., 2010; Mujal et al., 2009). High-energy dense nutrition is low in 
indigestible oligosaccharides and other dietary fibers. Chronic high fat intake and low 
dietary fiber intake may lead to gut microflora changes, specifically to Bifidobacterium spp. 
number decrease (Cani & Delzenne, 2009). Altered microflora may play an important role  
in obesity initiation and homeostasis perturbation (Cani et al., 2007a; Cani et al., 2009; 
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Heilbronn & Campbell, 2008). Lipopolysaccharides [LPS] from Gram negative bacteria (in 
altered gut microflora) promote secretion of inflammatory cytokines. LPS pass through 
intestinal wall, travel by chylomicrons to target organs where they promote inflammation-
induced metabolic disorders (obesity, insulin resistance, macrophage infiltration into 
adipose tissue, liver steatosis). Bifidobacterium spp. as an important actor in healthy gut 
microflora, decreases the levels of intestinal endotoxins and enhances mucosal barrier 
function (Tuohy et al., 2005). Increasing the intake of prebiotics may be a beneficial strategy 
in keeping the number of Bifidobacterium spp. optimal and gut microflora healthy and 
functional, reducing low-grade inflammation (Tohuy et al., 2005; Cani et al., 2007b). 
According to Goodlad et al. "prebiotic dietary fibers may also modulate other targets prone 
to influence metabolic disorders associated with obesity, such as gut peptides" (Goodlad et 
al., 1987). Decreasing low-grade inflammation and beneficially influencing the body mass, 
prebiotics (together with probiotics) may be a factor in cancer risk reduction (Grey, 2006; 
Tuohy et al., 2005; Cani et al., 2007a; Goodlad et al., 1987; World Gastroenterology 
Organisation, 2008; Donaldson, 2004; Yan & Polk, 2010). Jain et al. indicated that certain 
synbiotics (combinations of prebiotics and probiotics) are more efficient in vivo than in 
either treatment alone, but that more research is needed to identify the most potent 
synbiotics (Jain et al., 2010). 
2.2.3 Milk and dairy products 
Milk and dairy products are sources of many essential nutrients, e.g. amino acids, fatty 
acids, lactose, vitamin D, vitamin A, vitamin B12, calcium, potassium and they are 
prerequisites for growth and development, as well as for optimal bone health (USDA & U.S. 
Department of Health and Human Services, 2011; Smolin & Grosvenor, 2010). The strength 
of evidence suggesting that intake of milk and dairy products is associated with reduced 
cardiovascular and type 2 diabetes risks and blood pressure lowering is moderate (Smolin  
& Grosvenor, 2010; Huth & al., 2006). A large number of epidemiological studies were 
conducted in order to explore the relations between milk and dairy products consumption 
and cancer risks, but the results were largely equivocal (Huth & al., 2006; Quigley, 2011; 
Järvinen, 2011; Van der Pols et al., 2007). Chronic excessive intake of dairy fat can promote 
development of malignancies, but certain fatty acids from milk, like conjugated linoleic acid 
[CLA] can inhibit cancer growth. Vitamin D3 may reduce the risk of prostate cancer. 
Calcium from milk and dairy products may have protective properties against colon cancer, 
while bovine lactoferrin from whey may inhibit colon carcinogenesis (Tsuda et al., 2000; 
Aune et al., 2011). 
The aforementioned contradictory results do not undermine the importance of milk and 
dairy products in daily diet. Dietary Guidelines for Americans, 2010  recommendations for 
dairy intake are in accordance with cancer risk reduction (USDA & U.S. Department of 
Health and Human Services, 2011; Smolin & Grosvenor, 2010). 
2.2.4 Protein foods 
ChooseMyPlate nutrition guide classifies meat, fish, eggs and their products, legumes, nuts 
and seeds as protein foods (USDA, 2011b). Proteins have not been linked with increase in 
obesity, diabetes or cancer risks (WHO, 2007a; Joslin Diabetes Center & Joslin Clinic, 2007), 
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but foods from this group are rich sources of fats, oils and other substances that might affect 
cancer risks (Smolin & Grosvenor, 2010; USDA, 2011b). 
The majority of case-control studies suggested a positive link between meat consumption 
and colorectal cancer risk (WCRF & AICR, 2007; Gonzalez, 2006; Chan et al., 2011). 
Globally, meat and meat products account for 8.0% of the daily energy intake (FAO, 2011). 
On account of essential amino acids, fatty acids, vitamin B12, folates, iron, copper and zinc 
content, meat should be consumed on a daily basis. The amount and the percentage of fat in 
consumed meat, as well as the type of processing correlate with the incidence of colorectal 
malignancies (Gonzalez, 2006; Chan et al., 2011; Cross & Sinha, 2004). Risk factors associated 
with consumption of meat and meat products include nitrates, nitrites, N-nitroso 
compounds, heterocyclic amines and polycyclic aromatic carbohydrates. Iron is also 
considered to be a risk factor, because of its prooxidative properties (WCRF & AICR, 2007; 
Cross & Sinha, 2004; Eichholzer & Gutzwiller, 1998; Lanou & Svenson, 2010; Butler et al., 
2003; Zheng et al., 2009). The overall evidence supports limiting red and processed meat 
intake in order to reduce the risk of colorectal cancer (WCRF & AICR, 2007; Key et al., 2004; 
Béliveau & Gingras, 2007; Kushi, 2006). 
Dietary fatty acid composition plays a role in the process of carcinogenesis and tumor 
proliferation (WCRF & AICR, 2007; Fenech et al., 2011; WHO, 2008a; FAO, 2004; USDA & 
U.S. Department of Health and Human Services, 2011; Chan & Giovannucci, 2010; Hu et al., 
2011a). The single most prominent issue responsible for global increase of total dietary fat 
and saturated fatty acids intake is the process of hydrogenation of oils (USDA & U.S. 
Department of Health and Human Services, 2011; Van Stuyvenberg, 1969). Total 
hydrogenation transforms unsaturated fatty acids from fish oil and plant oils to saturated 
fatty acids, while partial hydrogenation produces unsaturated trans-fatty acids. When 
consumed, trans-fatty acids act as saturated (USDA & U.S. Department of Health and 
Human Services, 2011; Van Stuyvenberg, 1969). WCRF (WCRF & AICR, 2007) and North 
Carolina Colon Cancer Study (Vinikoor et al., 2009) claim that specific effects of trans-fatty 
acids on cancer risk is not known, since positive correlation linking trans-fatty acids intake 
and overall cancer prevalence was detected using mailed food questionnaires (Hu et al., 
2011b). 
Data on health effects of fatty fish intake, the correlation between fatty fish intake and 
gastric cancer (Wu et al., 2011), breast cancer (Terry et al., 2003; Murff et al., 2011), prostate 
cancer (Terry et al., 2003; Allen et al., 2004) and colorectal cancer (Aune et al., 2009a; 
Vinikoor et al., 2009; Daniel et al., 2009) are inconsistent (Daniel et al., 2009). Long-chain 
polyunsaturated fatty acids from fish are seen as promising nutrients in cancer prevention, 
but currently there is not enough supportive scientific evidence. On the other hand, intake 
of α-linolenic acid might be a risk factor for cancer (Daniel et al., 2009; Colquhoun et al., 
2009). New studies, both experimental and epidemiological, are necessary to shed more 
light on these findings. 
The link between eggs consumption and cancer has not been researched as extensively. 
Currently, the evidence suggest that eggs intake may be linked to increase in colon, rectal, 
bladder and ovarian cancer risks, putting into consideration the use of dietary alternatives 
to eggs (Zhang et al., 2003; Radosavljević et al., 2005; Aune et al., 2009). 
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Legumes are known to be beneficial in cardiovascular and type 2 diabetes risk reduction, 
but there is limited evidence that legumes consumption may reduce the risk of stomach, 
colorectal, and kidney cancer. Further investigations of these complex relations are still 
waited upon (Kolonel et al., 2000; Aune et al., 2009b). 
Effects of nuts and seeds intake on cancer risks are limited and inconclusive (WCRF & 
AICR, 2007). 
Aflatoxin contamination of fungus-contaminated crops and legumes remains a serious food 
safety problem, as aflatoxin is known to be a risk for liver cancer (Goldman & Shields, 2003; 
Wogan et al., 2004).  
2.2.5 Table salt 
Chronic intake of excessive amounts of table salt is a possible gastric cancer risk factor 
(WCRF & AICR, 2007; ADA, 2006a; Key et al., 2004; Béliveau et al., 2007; WHO, 2003, 2005; 
AICR & WCRF, 2009; Donaldson, 2004). As positive correlation between Helicobacter pylori 
infection and high salt intake has also been noted, it is possible that there is a synergy 
between the two factors in gastric cancer promotion. Another mechanism of stomach cancer 
promotion proposed is that high salt intake damages the gastric mucose, increasing the 
possibility of endogenous mutations, which leads to hypergastrinemia and decrease in 
number of gastric parietal cells, and thus to cancer promotion (Wang et al., 2009). 
Processed foods are the main source of salt in the diet, and in order to reduce cancer risks in 
adult population, population-level strategy should start by decreasing salt intake among 
children, adolescents and young adults (Trajković-Pavlović et al., 2010a, 2010b).  
2.2.6 Vitamins, minerals and other bioactive molecules 
Micronutrients, such as vitamins and minerals, are essential nutrients in maintaining good 
health, while other bioactive molecules, such as phytochemicals (substances of plant origin) 
and zoochemicals (substances of animal origin) are non-essential, but may improve human 
health (Kaput, 2006). Recommendations for vitamin and mineral intake exist for different 
population groups (Institute of Medicine, 1998, 2000, 2001), but it is not possible to quantify 
the need for phytochemicals (Smolin & Grosvenor, 2010). 
Many vitamins (e.g vitamin E, vitamin C), minerals (e.g selenium) and phytochemicals (e.g 
flavonoids) are parts of the antioxidant defense system. Substances with antioxidant 
properties were seen as promising in lowering risks from chronic diseases and, among 
them, cancer. In vitro experiments have confirmed that these molecules have antioxidant 
properties, but the initial hypothesis that antioxidant substances can prevent cancer (or 
other chronic diseases) in humans has yet to be confirmed (WCRF & AICR, 2007; Mamede et 
al., 2011). 
The impact of calcium and vitamin D on breast and colorectal cancer is being intensively 
researched during the last ten years, but, up to this point, no definite answers can be given 
about these relations (Lin et al., 2007; Lappe et al., 2007; Manson et al., 2011). 
In the complex pathways of carcinogenesis, there are numerous processes that could be 
targeted by phytochemicals in order to lower the risk of disease development. The interest 
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in phytochemicals has grown substantially over the years and it has not lessen, although 
screening for potential chemopreventive molecules requires a systematic and wide-range 
approach (Tan et al., 2011; Milner, 2004). In order to reduce the risk of cancer in human 
population, many experiments studying herbs and spices and their effects on carcinogenesis 
were conducted on animals. The possibility of using herbs and spices as substitutes for 
unhealthy food constituents (e.g added sugars, added fat, table salt) can contribute to 
chemopreventive potential of herbs and spices (Tapsell et al., 2006). 
If phytochemicals are added to foods, such foods become functional. Functional foods are 
foods that provide healthy benefits beyond basic nutrition, when consumed as part of a 
varied diet on a regular basis, at effective levels (ADA, 2009; Howlett, 2008). According to 
some authors, health effects of consuming functional foods containing bioactive substances 
or pharmaceuticals may be as beneficial as consumption of those substances from their 
natural sources (Howlett, 2008). Other authors claim that chemopreventive properties of 
fruits and vegetables are a result of synergistic and additive effects of phytochemicals acting 
together in their natural environment, and therefore, cannot be imitated by functional foods 
(Tapsell et al., 2006; Liu, 2003; Milner, 2006b). 
Global use of dietary supplements containing vitamins, minerals and other bioactive 
compounds, although already enormous, is still on the rise. Dietary supplements can reduce 
the risk of deficiencies and promote optimal health, but should not be considered substitutes 
for a well-balanced, healthy diet (Mason, 2007). Evidence supporting the use of dietary 
supplements in cancer risk reduction are scarce, so population-based recommendation is to 
increase the percentage of people who are achieving optimal nutrition without the use of 
dietary supplements (WCRF & AICR, 2007; Myung et al., 2009). Determination of oxidative 
stress-based biomarkers should be regarded as "indication" for using antioxidant 
supplements (Ziech et al., 2010), although this is not financially viable yet. 
Mediterranean diet is considered to be protective against cancers, opposite to USA and 
Northern Europe diet patterns. Adoption of Mediterranean eating pattern in USA and 
Northern Europe may help cancer risk reduction (Simopoulos, 2001; Verberne et al., 2010).  
2.3 Physical activity 
Regular physical activity, besides leading to fitness, provides many health benefits 
(Warburton et al., 2006; Miles, 2007). Physical activity increases overall well-being, and if 
regular, improves quality of life, helps body mass maintenance and therefore, reduces 
cancer risks (WCRF & AICR, 2007; WHO, 2003, 2005, 2008a, 2009b; AICR & WCRF, 2009). 
Cancer risks in regularly physically active are up to 40.0% lower than among physically 
inactive (Newton & Galvão, 2008). 
Insufficient physical activity is considered to be the fourth leading risk factor in overall 
mortality. WHO holds insufficient physical activity responsible for 6.0% of global deaths 
(WHO, 2009a). Dropping levels of physical activity worldwide are in part responsible for 
rising prevalence of NCDs, including cardiovascular diseases, diabetes and cancer (WCRF & 
AICR, 2007; WHO, 2005, 2009a; Fair & Montgomery, 2009; AICR & WCRF, 2009; Newton & 
Galvão, 2008; Tucker et al., 2011; Hardman et al., 2011; Wannamethee et al., 2001). 
Insufficient physical activity accounts for 21.0-25.0% of breast and colon cancer burden 
(WHO, 2009a, 2010a) 
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Physical inactivity is a modifiable lifestyle choice and a cancer risk factor, and it is therefore 
of great public health significance (WCRF & AICR, 2007; WHO, 2005; AICR & WCRF, 2009; 
Warburton et al., 2006; Miles, 2007; Newton & Galvão, 2008; Tucker et al., 2011; Hardman, 
2001; Wolin et al., 2009), but meeting  physical activity recommendations has proven to be as 
big of a challenge on an individual level, as on the society one. 
The complexity of cancer - physical activity interactions should be assessed on gene level, 
too. Thune & Furberg (Thune & Furberg, 2001) believe that "genetic predisposition to be 
physically active, combined with the knowledge that cancer is a genetic localized disease, 
warrants studies in general population and high-risk groups alike". 
Physical activity is divided into inactivity, insufficient activity and sufficient activity. 
Sufficient activity is subdivided into "meeting current recommendations" (moderate 
physical activity) and "highly active" (WHO, 2007b, 2009a, 2009b, 2010a). 
"Meeting current recommendations" is possible by 2.5 hours of moderate physical activity, 
or 1 hour of vigorous physical activity per week. Both are equivalent with 600 metabolic 
equivalents [MET] per week. Highly active individuals' energy expenditure is equivalent to 
1600 MET per week. Metabolic equivalent is the ratio of energy consumption during a 
specific physical activity to energy consumption while sitting and resting. One MET is 
defined as the resting metabolic rate obtained during quiet sitting and is set by convention 
to 3.5 ml O2/kg/min or 1 kcal/kg/h (WHO, 2010a). Physical activities are classified 
according to energy needed for their performance, using MET as a reference value. On a 
population level, moderate physical activity should be set as a goal for health benefits and 
cancer risk reduction. Indivividuals and population groups that are already moderately 
active, should be encouraged to become highly active. 
In the "Global Recommendations on Physical Activity and Health" (WHO, 2010a), WHO 
aims to establish dose-response relationship between physical activity and the consequent 
health benefits, as well as to identify the frequency, duration, intensity, type and total 
amount of physical activity needed for health benefits, such as cancer or other NCDs risk 
reduction (WHO, 2007b, 2009b, 2010a). Currently, it is believed that diabetes, heart diseases 
and cancer risks, including breast and colon cancer risks, can be reduced among people who 
are 18 or older by 150 minutes of moderate intensity aerobic activity the least, or 60 minutes 
of vigorous activity weekly. At least 60 minutes of moderate to vigorous physical activity 
can reduce NCDs risks in 5-17 year-olds (WHO, 2009a, 2009b). For added health benefits, 
introduction of physical activity, with the amount, frequency, duration and intensity being 
gradually increased, is recommended for inactive adults, older adults and those limited in 
activity by their disease (WHO, 2010a). 
Public health goals set by new physical activity recommendations include achieving and 
maintaining optimal health (WCRF & AICR, 2007; WHO, 2003, 2005, 2007, 2008a, 2009a, 
2009b, 2010a; Wolin et al., 2009). 
2.4 Tobacco, alcohol use and everyday drinks 
Although alcoholic beverages and everyday drinks are considered foods, together with 
tobacco use, their consumption may pose a health risk. On the other hand, safe drinking 
water is not a health risk, but a prerequisite for optimal health. 
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2.4.1 Tobacco use 
Tobacco is a plant that contains nicotine, various carcinogens and toxins, and it is 
considered addictive (WHO, 2011d). Around 4000 chemicals have been detected in tobacco 
smoke, with more than 50 of them identified as carcinogenic (WHO, 2006). Tobacco 
dependence is classified as a disease under the International Classification of Diseases [ICD-
10] (WHO, 1999). 
Tobacco use has grown into a global epidemic. The number of tobacco users is on the rise in 
middle and low income countries, while in decline in developed countries (Mackay et al., 
2006; IARC, 2004; WHO, 2008b). Smoking is the second principal cause of global mortality 
participating with 8.7% (3.7% DALYs) (WHO, 2008b, 2009a; IARC, 2004). At the same time, 
smoking is the most modifiable single risk factor for malignant diseases and other NCDs 
(WHO, 2009a; Danaei et al., 2009). 
Smoking causes 71.0% of lung cancer deaths (WHO, 2009a), but it is also a risk for other 
cancer localizations, like throat, mouth, esophagus, stomach, pancreas, kidney, bladder and 
cervix (WHO, 1999, 2011d). Not only smokers die of smoking-related lung cancer – 4300 
secondhand smokers die from lung cancer every year in USA (IARC, 2004; WHO, 2008b, 
2011e). 
Tobacco use, in any form, is unhealthy. Attempts were made to create less toxic versions of 
tobacco products, but such products were unacceptable by consumers and consequently 
failed. Although not widely used, in some parts of the world smokeless tobacco represents a 
significant form of tobacco use (WHO, 2006; IARC, 2004, 2006, 2008). 
Definitions of smoking and related terms – secondhand tobacco smoke [SHS], 
environmental tobacco smoke [ETS] or other people's smoke and smoking free area – are 
given in WHO Framework Convention on Tobacco Control [WHO FCTC] as recommended 
terms for smoking and secondhand smoke (WHO, 2006, 2011e). 
WHO FCTC aims to protect public health policy makers from commercial interests, to 
provide guidance for protection against tobacco smoke, to regulate the contents of tobacco 
products, to implement rules for labelling, advertising and promotion of tobacco products, 
to educate people and communicate information about tobacco addiction. Ultimately, the 
goal is to decrease the number of tobacco users and increase the number of former smokers 
(WHO, 2011e; IARC, 2008). 
There are several aspects of harmful effects of smoking. Dietary nutrient intake and plasma 
folate level can also be affected by smoking status. Depletion of plasma folate, an 
antioxidant, together with depletion of other dietary substances, might be a factor in early 
onset of tobacco-related morbidity and mortality in smokers. Beneficial effects of 
Mediterranean diet on smokers' health have been documented and they are presumably 
related to optimal ratio of omega-6 to omega-3 polyunsaturated fatty acids and significant 
amounts of bioactive molecules (Vardavas et al., 2008, 2011). 
In conclusion, all tobacco products should be considered harmful and addictive, and strict 
regulations should be implemented in order to control the tobacco epidemic (WHO, 2011e; 
IARC, 2008). Public health researchers of the Oxford Vision 2020 Program, underlined not 
only the societal, but the individual responsibility towards health and healthy lifestyle 
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choices. Being aware of the health risks related to tobacco use is not merely enough – 
motivational campaigns should be designed in order to cut down smoking prevalence by 8.0 
to 10.0% per year, and achieve the resulting prevalence of less than 10.0% in all social 
groups (Yach et al., 2005). 
2.4.2 Alcohol use 
WHO has estimated that alcohol consumption causes 3.5% of global deaths (6.2% among 
males, and 1.1% among females) (WHO, 2011f), and it is responsible for 4.5% of DALYs 
(WHO, 2011f). 
The link between alcohol intake and cancer is well documented. There is a positive 
correlation between oral, pharyngeal, laryngeal, esophageal, liver, colorectal (in men) 
(WCRF & AICR, 2007; WHO, 2009a, 2011f; Testino & Borro, 2010; Baan et al., 2007)  and 
breast cancer and intake of more than 30 g of alcohol/day (3 standard drinks/day) (Allen et 
al., 2009; Boyle & Boffetta, 2009). Heavy drinking may correlate with higher risk of lung and 
pancreatic cancer, but the epidemiological evidence supporting this hypothesis is weak 
(WCRF & AICR, 2007; WHO, 2011f; Testino & Borro, 2010).  
Heavy drinking is defined as intake of more than 80 g of alcohol per day, or more than 5 to 6 
standard drinks per day (Pöschl & Seitz, 2004). 
More than 30 codes of ICD-10 include the term "alcohol" in their name or definition, 
documenting the importance of alcohol-related health impairment (WHO, 1999). 
Health effects of alcohol vary depending on the age, gender and other characteristics of 
consumers, but they also depend on the setting and context of  drinking (Pöschl & Seitz, 
2004). 
International Agency for Cancer Research has stated that "acetaldehyde associated with 
alcoholic beverages is carcinogenic to humans (Group 1)" and confirmed the Group 1 
classification of alcohol consumption and of ethanol in alcoholic beverages (Secretan et al., 
2009). 
Acetaldehyde is the first and the most toxic metabolite of alcohol metabolism. Alcohol 
dehydrogenase [ADH] oxidizes alcohol to acetaldehyde, which is then converted to acetate 
by aldehyde dehydrogenase [ALDH]. Ethanol also inhibits DNA methylation and interacts 
with retinoid metabolism. Tissue-specific levels of ethanol are in correlation with the 
amount of alcohol ingested, but they also depend on the genotype coding for ethanol-
metabolizing enzymes, predominantly ALDH (Seitz & Stickel, 2007; Boffeta & Hashibe, 
2006; Seitz & Becker, 2007). 
Effects of acetaldehyde, elevated estrogen levels, production of oxygen radicals and changes 
in folate and vitamin B6 metabolism, may be mechanisms responsible for the genotoxicity of 
alcohol (Seitz & Stickel, 2007; Boffeta & Hashibe, 2006; Seitz & Becker, 2007). 
Persons with achlorhydric gastritis who consume alcohol are at greater risk of stomach 
cancer. Absence of hydrochloric acid creates an environment favorable for thriving of ADH-
containing bacteria that can metabolize carbohydrates to ethanol and acetaldehyde (Seitz & 
Becker, 2007). 
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The WHO Global Strategy to Reduce the Harmful Use of Alcohol (WHO, 2010b) aims to 
raise awareness of health, social and economic aspects of alcohol abuse, and the relationship 
between alcohol and disease development. It points to the importance of effective 
stakeholders involvement in preventing harmful effects of alcohol. It also aims to provide 
support for national efforts to reduce the overall effects of alcohol abuse. 
USDA recommendations for alcohol intake not linked  to increase of cancer risks are 28 g of 
alcohol per day for healthy adult men, and half of that amount for healthy women (USDA & 
U.S. Department of Health and Human Services, 2011). The European Code Against Cancer 
recommends up to 20 or 30 g/day of alcohol for healthy men and, again, half of that amount 
for healthy women (Boyle et al., 2003). AICR made recommendations simple by advising 2 
standard drinks for healthy men and 1 standard drink for healthy women (WCRF & AICR, 
2007). 
Tobacco and alcohol use are major risk factors for malignancies of different localizations, but 
mainly of the gastrointestinal tract (Testino & Borro, 2010; Pelucchi et al., 2008; Seitz & Cho, 
2009) and the two also act in synergy increasing the cancer risk. Tobacco smoking combined 
with alcohol use increase the tissue levels of acetaldehyde, while alcohol helps in activation 
of different procarcinogens in tobacco smoke by induction of cytochrome-P450-2E1-
dependent microsomal biotransformation system in mucose cells of the upper digestive 
tract and liver (IARC, 2004; Testino and Borro, 2010; Seitz & Cho, 2009). Pancreatic cancer 
risk is 4.3-fold higher in people who smoke more than 20 cigarettes per day and drink more 
than 21 standard drinks per week, than in non-smoking people who drink less than 7 
standard drinks per week (Talamini et al., 2010). 
2.4.3 Coffee and tea use 
Coffee and tea drinking is a widespread habit. Both coffee and tea contain many bioactive 
substances (antioxidants, phenols) with in vitro anticarcinogenic characteristics (Ferruzzi, 
2010). Consumption of 3 cups of coffee per day (equivalent to 300 mg of caffeine) is 
considered to be moderate (Tverdal et al., 2011). 
It is still not known whether coffee consumption increases the risk of any type of cancer. 
Evidence concerning the link between coffee and esophageal and pancreatic cancer are 
inconsistent and difficult to interpret, due to the confounding effects of tobacco and alcohol 
use (WCRF & AICR, 2007; Ferruzzi, 2010). 
Laboratory experiments and animal testing showed chemoprotective activity of tea 
polyphenols, but there are not enough evidence to confirm the same in human population 
(WCRF & AICR, 2007; Lambert & Yang, 2003). 
2.4.4 Soft drinks 
Soft drinks consumption shows an increase of 5.0% per year, that is an increase  from 467 to 
552 billion litres from 2004 to 2007 (Zenith International, 2005, 2008). Cola drinks and 
carbonated soft drinks reportedly accounted for 42.0% of 467 billion litres of soft drinks 
consumed within one year, in contrast to fruit juices, nectars and fruit drinks which 
accounted for 8.0% in 2004 (Zenith International, 2005). 
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Currently, findings on the effects of soft drinks on cancer risks are limited and inconsistent 
(WCRF & AICR, 2007). 
Soft drinks are significant contributors to added sugar intake which leads to body mass 
increase, overweigh, obesity and consequently to NCDs. Eminent international 
organizations do not consider soft drinks to be a part of healthy and active lifestyle (WCRF 
& AICR, 2007; WHO, 2005; USDA & U.S. Department of Health and Human Services, 2011). 
2.4.5 Water as a fluid of choice 
Only air is more crucial for life than water. Access to safe drinking water is a basic human 
right, as well as a condition for achieving and sustaining optimal health (WHO, 2011e). 
However, contaminated water is a great health risk. Inorganic arsenic from drinking water 
is a proven risk for lung cancer and there is limited evidence that it is also a risk factor for 
kidney and bladder cancer (WCRF & AICR, 2007). 
Safe drinking water is a nutrient per se. Because it plays many important roles in the human 
body, water is the fluid of choice as a part of healthy lifestyle. There has been a steady 
growth in the sales of bottled water (6.1% in 2007) (Zenith International, 2008) which is an 
encouraging fact in accordance with today΄s active and healthy lifestyle. 
Daily requirements for water depend on age, gender, pregnancy, lactation, physical activity 
level, diet and external conditions (Smolin & Grosvenor, 2010; ILSI, 2004).  
3. Conclusion 
The impact of nutrition and lifestyle on cancer development is evident. Still, there are many 
unanswered questions concerning the interactions among nutrition, environment and 
human genome. The existing and future knowledge should be used by public health 
professionals to promote cancer risk reduction  on a population scale, especially in high risk 
subpopulations, as well as on the individual level. Further research and public health 
activities should be supported by health and government authorities. 
"To eat is a necessity, to eat intelligently is an art." (François de La Rochefoucauld, French 
writer, 1613-1680)  
"Walking is man's best medicine." (Hippocrates, ancient Greek physician, 460 BC – 377 BC) 
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